Andrea S Fung

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Locally Advanced

Small Cell Lung Cancer

Placebo Controlled

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Marcin Dzienis, Juan Cundom, Christian Sebastian Fuentes, Anna Spreafico, Melanie Nordlinger, Andrea Viviana Pastor, Erin R Alesi, Anterpreet Neki, Andrea S Fung, Iane Pinto Figueiredo Lima, Peter Oppelt, Geraldo Felicio da Cunha Junior, Barbara A Burtness, Fabio Andre Franke, Jennifer E Tseng, Abhishek Joshi, Joy McCarthy, Ramona Swaby, Yulia Sidi, Burak Gumuscu, Niroshini Naicker, Gilberto de Castro Junior
Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Marcin Dzienis, Juan Cundom, Christian Sebastian Fuentes, Anna Spreafico, Melanie Nordlinger, Andrea Viviana Pastor, Erin R Alesi, Anterpreet Neki, Andrea S Fung, Iane Pinto Figueiredo Lima, Peter Oppelt, Geraldo Felicio da Cunha Junior, Barbara A Burtness, Fabio Andre Franke, Jennifer E Tseng, Abhishek Joshi, Joy McCarthy, Ramona Swaby, Yulia Sidi, Burak Gumuscu, Niroshini Naicker, Gilberto de Castro Junior
Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Marcin Dzienis, Juan Cundom, Christian Sebastian Fuentes, Anna Spreafico, Melanie Nordlinger, Andrea Viviana Pastor, Erin R Alesi, Anterpreet Neki, Andrea S Fung, Iane Pinto Figueiredo Lima, Peter Oppelt, Geraldo Felicio da Cunha Junior, Barbara A Burtness, Fabio Andre Franke, Jennifer E Tseng, Abhishek Joshi, Joy McCarthy, Ramona Swaby, Yulia Sidi, Burak Gumuscu, Niroshini Naicker, Gilberto de Castro Junior
Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Marcin Dzienis, Juan Cundom, Christian Sebastian Fuentes, Anna Spreafico, Melanie Nordlinger, Andrea Viviana Pastor, Erin R Alesi, Anterpreet Neki, Andrea S Fung, Iane Pinto Figueiredo Lima, Peter Oppelt, Geraldo Felicio da Cunha Junior, Barbara A Burtness, Fabio Andre Franke, Jennifer E Tseng, Abhishek Joshi, Joy McCarthy, Ramona Swaby, Yulia Sidi, Burak Gumuscu, Niroshini Naicker, Gilberto de Castro Junior
Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Andrea S Fung, Karen Kopciuk, Michelle L Dean, Adrijana D'Silva, Shannon Otsuka, Alexander Klimowicz, Desiree Hao, Don Morris, D Gwyn Bebb
CXCR4 expression in lung carcinogenesis: Evaluating gender-specific differences in survival outcomes based on CXCR4 expression in early stage non-small cell lung cancer patients. PloS one 16 (1) (2021)
Andrea S Fung, Vincent C Tam, Daniel E Meyers, Hao-Wen Sim, Jennifer J Knox, Valeriya Zaborska, Janine Davies, Yoo-Joung Ko, Eugene Batuyong, Haider Samawi, Winson Y Cheung, Richard Lee-Ying
Second-line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real-world eligibility for cabozantinib, regorafenib, and ramucirumab. Cancer medicine 9 (13) (2020)
Andrea S Fung, Arfan Raheen Afzal, Robyn Banerjee, Brock Debenham, Desiree Hao
A real-world comparison of cisplatin vs cetuximab used concurrently with radiation in the treatment of locally advanced oropharyngeal carcinoma. Head & neck 43 (1) (2020)